ASCO: Pembrolizumab Plus Lenalidomide Gets Response in MM (CME/CE)

(MedPage Today) -- Combo shows signs of benefit in relapsed/refractory myeloma
Source: MedPage Today State Required CME - Category: Consumer Health News Source Type: news
More News: Health | Myeloma | Revlimid